TY - JOUR AU - Cunningham, D. PY - 2006 DA - 2006// TI - Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa055531 DO - 10.1056/NEJMoa055531 ID - Cunningham2006 ER - TY - JOUR AU - Ychou, M. PY - 2011 DA - 2011// TI - Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.0597 DO - 10.1200/JCO.2010.33.0597 ID - Ychou2011 ER - TY - JOUR AU - Lordick, F. PY - 2007 DA - 2007// TI - PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70244-9 DO - 10.1016/S1470-2045(07)70244-9 ID - Lordick2007 ER - TY - JOUR AU - Yoshioka, T. PY - 2003 DA - 2003// TI - Evaluation of 18 F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer JO - J Nucl Med VL - 44 ID - Yoshioka2003 ER - TY - JOUR AU - Kim, S. K. PY - 2006 DA - 2006// TI - Assessment of lymph node metastases using 18 F-FDG PET in patients with advanced gastric cancer JO - Eur J Nucl Med Mol Imaging VL - 33 UR - https://doi.org/10.1007/s00259-005-1887-8 DO - 10.1007/s00259-005-1887-8 ID - Kim2006 ER - TY - JOUR AU - Toyohara, J. PY - 2002 DA - 2002// TI - Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines JO - Nucl Med Biol VL - 29 UR - https://doi.org/10.1016/S0969-8051(02)00286-X DO - 10.1016/S0969-8051(02)00286-X ID - Toyohara2002 ER - TY - JOUR AU - Ott, K. PY - 2011 DA - 2011// TI - Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-1743-y DO - 10.1245/s10434-011-1743-y ID - Ott2011 ER - TY - JOUR AU - Kameyama, R. PY - 2009 DA - 2009// TI - Detection of gastric cancer using 18 F-FLT PET: comparison with 18 F-FDG PET JO - Eur J Nucl Med Mol Imaging VL - 36 UR - https://doi.org/10.1007/s00259-008-0970-3 DO - 10.1007/s00259-008-0970-3 ID - Kameyama2009 ER - TY - JOUR AU - Zhou, M. PY - 2013 DA - 2013// TI - 18 F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18 F-FDG PET/CT imaging JO - Nucl Med Commun VL - 34 UR - https://doi.org/10.1097/MNM.0b013e328361663a DO - 10.1097/MNM.0b013e328361663a ID - Zhou2013 ER - TY - JOUR AU - Park, S. H. PY - 2012 DA - 2012// TI - The feasibility of (18)F-fluorothymidine PET for prediction of tumor response after induction chemotherapy followed by chemoradiotherapy with S-1/oxaliplatin in patients with resectable esophageal cancer JO - Nucl Med Mol Imaging VL - 46 UR - https://doi.org/10.1007/s13139-011-0118-4 DO - 10.1007/s13139-011-0118-4 ID - Park2012 ER - TY - JOUR AU - Gray, K. R. PY - 2010 DA - 2010// TI - Kinetic filtering of [(18)F]fluorothymidine in positron emission tomography studies JO - Phys Med Biol VL - 55 UR - https://doi.org/10.1088/0031-9155/55/3/010 DO - 10.1088/0031-9155/55/3/010 ID - Gray2010 ER - TY - JOUR AU - Kenny, L. M. PY - 2005 DA - 2005// TI - Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18 F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-4297 DO - 10.1158/0008-5472.CAN-04-4297 ID - Kenny2005 ER - TY - JOUR AU - Contractor, K. B. PY - 2011 DA - 2011// TI - [18 F]-3’Deoxy-3’-fluorothymidine positron emission tomography and breast cancer response to docetaxel JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0783 DO - 10.1158/1078-0432.CCR-11-0783 ID - Contractor2011 ER - TY - JOUR AU - Eisenhauer, E. A. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Wahl, R. L. PY - 2009 DA - 2009// TI - From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.057307 DO - 10.2967/jnumed.108.057307 ID - Wahl2009 ER - TY - JOUR AU - Simoncic, U. AU - Jeraj, R. PY - 2014 DA - 2014// TI - Heterogeneity in stabilization phenomena in FLT PET images of canines JO - Phys Med Biol VL - 59 UR - https://doi.org/10.1088/0031-9155/59/24/7937 DO - 10.1088/0031-9155/59/24/7937 ID - Simoncic2014 ER - TY - JOUR AU - Contractor, K. PY - 2012 DA - 2012// TI - Imaging of cellular proliferation in liver metastasis by [18 F]fluorothymidine positron emission tomography: effect of therapy JO - Phys Med Biol VL - 57 UR - https://doi.org/10.1088/0031-9155/57/11/3419 DO - 10.1088/0031-9155/57/11/3419 ID - Contractor2012 ER - TY - JOUR AU - Challapalli, A. PY - 2015 DA - 2015// TI - 3’-Deoxy-3’-(1)(8)F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3000-2 DO - 10.1007/s00259-015-3000-2 ID - Challapalli2015 ER - TY - JOUR AU - Kapoor, H. AU - Agrawal, D. K. AU - Mittal, S. K. PY - 2015 DA - 2015// TI - Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny JO - Transl Res VL - 166 UR - https://doi.org/10.1016/j.trsl.2015.01.009 DO - 10.1016/j.trsl.2015.01.009 ID - Kapoor2015 ER - TY - JOUR AU - Chalkidou, A. PY - 2012 DA - 2012// TI - Correlation between Ki-67 immunohistochemistry and 18 F-fluorothymidine uptake in patients with cancer: a systematic review and meta-analysis JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.05.001 DO - 10.1016/j.ejca.2012.05.001 ID - Chalkidou2012 ER - TY - JOUR AU - Westreenen, H. L. PY - 2005 DA - 2005// TI - Comparison of 18 F-FLT PET and 18 F-FDG PET in esophageal cancer JO - J Nucl Med VL - 46 ID - Westreenen2005 ER - TY - JOUR AU - Tehrani, O. S. AU - Shields, A. F. PY - 2013 DA - 2013// TI - PET imaging of proliferation with pyrimidines JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.112201 DO - 10.2967/jnumed.112.112201 ID - Tehrani2013 ER - TY - JOUR AU - Ullrich, R. T. PY - 2008 DA - 2008// TI - Early detection of erlotinib treatment response in NSCLC by 3’-deoxy-3’-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET) JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0003908 DO - 10.1371/journal.pone.0003908 ID - Ullrich2008 ER - TY - JOUR AU - Kenny, L. PY - 2007 DA - 2007// TI - Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3’-deoxy-3’-[18 F]fluorothymidine positron emission tomography JO - Eur J Nucl Med Mol Imaging VL - 34 UR - https://doi.org/10.1007/s00259-007-0379-4 DO - 10.1007/s00259-007-0379-4 ID - Kenny2007 ER - TY - JOUR AU - Chen, H. PY - 2015 DA - 2015// TI - 3’-deoxy-3’-[(1)(8)F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [(1)(8)F]-FDG PET/CT JO - Strahlenther Onkol VL - 191 UR - https://doi.org/10.1007/s00066-014-0744-8 DO - 10.1007/s00066-014-0744-8 ID - Chen2015 ER - TY - JOUR AU - Yue, J. PY - 2010 DA - 2010// TI - Measuring tumor cell proliferation with 18 F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study JO - J Nucl Med VL - 51 UR - https://doi.org/10.2967/jnumed.109.072124 DO - 10.2967/jnumed.109.072124 ID - Yue2010 ER - TY - JOUR AU - Weber, W. A. PY - 2001 DA - 2001// TI - Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging JO - J Clin Oncol VL - 19 ID - Weber2001 ER - TY - JOUR AU - Herrmann, K. PY - 2007 DA - 2007// TI - Imaging gastric cancer with PET and the radiotracers 18 F-FLT and 18 F-FDG: a comparative analysis JO - J Nucl Med VL - 48 UR - https://doi.org/10.2967/jnumed.107.044867 DO - 10.2967/jnumed.107.044867 ID - Herrmann2007 ER - TY - JOUR AU - Wang, C. PY - 2016 DA - 2016// TI - The predictive and prognostic value of early metabolic response assessed by positron emission tomography in advanced gastric cancer treated with chemotherapy JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-14-3235 DO - 10.1158/1078-0432.CCR-14-3235 ID - Wang2016 ER - TY - JOUR AU - Lundsgaard Hansen, M. PY - 2014 DA - 2014// TI - Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer—a prospective study JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0097605 DO - 10.1371/journal.pone.0097605 ID - Lundsgaard Hansen2014 ER - TY - JOUR AU - Kenny, L. M. PY - 2009 DA - 2009// TI - Altered tissue 3’-deoxy-3’-[18 F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1213 DO - 10.1158/1078-0432.CCR-09-1213 ID - Kenny2009 ER - TY - JOUR AU - Perumal, M. PY - 2006 DA - 2006// TI - Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-0898 DO - 10.1158/0008-5472.CAN-06-0898 ID - Perumal2006 ER -